FABTECH vs KPL: Stock Comparison
KWALITY PHARMACEUTICALS L is the larger company by market capitalisation. FABTECH TECHNOLOGIES shows a lower P/E, a higher dividend yield and faster revenue growth, while KWALITY PHARMACEUTICALS L shows a higher ROE, a higher ROCE and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
FABTECH leads 6; KPL leads 7 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | FABTECH | KPL |
|---|---|---|
| Sector | Healthcare | — |
| Industry | Medical Equipment & Supplies | — |
Price
| Metric | FABTECH | KPL |
|---|---|---|
| Live Price | ₹148.81 | ₹3,753.4 |
| Day Change | 1.07% | -2.38% |
| Volume | 22,653 | 26,161 |
| 52-Week High | ₹262.8 | ₹3,949 |
| 52-Week Low | ₹132.7 | ₹1,561 |
| Distance from 52W High | -43.38% | -4.95% |
Valuation
| Metric | FABTECH | KPL |
|---|---|---|
| Market Cap | ₹658 Cr | ₹3,878 Cr |
| P/E Ratio | 13.38x | 49.08x |
| P/B Ratio | 1.55x | 12x |
| EPS | ₹10.96 | ₹24.7 |
| Book Value | ₹109.44 | ₹317.96 |
| Dividend Yield | 0.41% | 0% |
Growth
| Metric | FABTECH | KPL |
|---|---|---|
| Revenue Growth (TTM YoY) | 17.5% | 0% |
| EPS Growth (TTM YoY) | 23.4% | 0% |
| Qtr Sales Growth | -34.46% | 0% |
| Qtr Profit Growth | -74.83% | -0.02% |
Profitability & Leverage
| Metric | FABTECH | KPL |
|---|---|---|
| ROE | 6.22% | 20.2% |
| ROCE | 6.94% | 16.32% |
| Net Margin | 11.28% | 13.39% |
| Operating Margin | 13.72% | 19.97% |
| Debt to Equity | 0.05x | 0.39x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | FABTECH | KPL |
|---|---|---|
| Promoter Holding | 68.94% | 54.86%▼ 0.01 pp |
| FII Holding | 0.02%▼ 0.06 pp | 3.13%▲ 0.34 pp |
| DII Holding | 2.45%▲ 0.3 pp | 0.56%▲ 0.2 pp |
| Public Holding | 28.58%▼ 0.25 pp | 41.44%▼ 0.54 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: FABTECH TECHNOLOGIES and KWALITY PHARMACEUTICALS L.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.